Physician profile
Mark Schwartz
NPI 1033422332
$19,627.73
in general payments reported to CMS, 2019-2025
28 companies · $2,075 in 2025
The $2,075 reported for 2025 was more than what 82% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,103 · 2020: $2,274 · 2021: $4,381 · 2022: $3,113 · 2023: $1,018 · 2024: $1,663 · 2025: $2,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,847 · Travel and Lodging: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,847.03 |
| Travel and Lodging | $909.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $4,479.06 | 2019-2022 | |
| Stryker Corporation | $4,268.05 | 2019-2025 | Gamma, Aequalis Ascend Flex, Asnis |
| Arthrex, INC. | $4,084.90 | 2021-2025 | |
| Pylant Medical | $2,928.04 | 2019-2025 | |
| Depuy Synthes Sales INC. | $481.59 | 2019-2025 | Lcp, Na, Va-Lcp |
| Baxter Healthcare | $392.31 | 2023-2025 | Floseal, Tisseel, Perclot |
| Bioventus LLC | $358.94 | 2023-2024 | Bonescalpel, Bonescalpel & Sonicone (O.R.) |
| Skeletal Dynamics INC | $322.05 | 2021-2024 | Implate, Align, Geminus |
| Smith+Nephew, INC. | $285.92 | 2020-2025 | Evos, Acticoat 4" X 4" |
| Alafair Biosciences, INC. | $250.85 | 2022-2024 | Versawrap |
| Polynovo North America LLC | $233.79 | 2024 | Novosorb Btm |
| Innovation Technologies INC | $227.61 | 2021 | |
| Osteocentric Technologies, INC. | $201.25 | 2022 | |
| Miach Orthopaedics, INC. | $155.08 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $155.03 | 2022-2025 | Iovera |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $142.76 | 2019 | |
| Ossio INC | $134.36 | 2023 | |
| Zimvie INC. | $126.93 | 2022 | |
| Medline Industries LP | $113.83 | 2021 | |
| Solventum Corporation | $68.97 | 2025 | Activ.A.C., Prevena, 3m Cavilon |
| Ethicon US, LLC | $55.71 | 2023-2024 | Dermabond Prineo, Surgiflo Hemostatic Matrix, Monocryl |
| Orthopediatrics Corp. | $34.99 | 2022 | |
| Biocomposites INC | $34.88 | 2025 | Stimulan |
| Highridge Medical LLC | $25.01 | 2024 | The Tether |
| Ultragenyx Pharmaceutical INC. | $18.52 | 2021 | |
| Aesculap, INC. | $18.12 | 2023 | Aesculap |
| Dynasplint Systems INC. | $15.37 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.